Insights

Gathering insights about VidIt…

Similar companies to VidIt

VidIt Tech Stack

VidIt uses 8 technology products and services including WordPress, Cloudflare, Nuxt.js, and more. Explore VidIt's tech stack below.

WordPress
Content Management System
Cloudflare
Content Management System
Nuxt.js
Javascript Frameworks
Vue.js
Javascript Frameworks
Video.js
Javascript Libraries
HighLevel
Marketing Automation
PHP
Programming Languages
reCAPTCHA
Security

Media & News

3 Potential Mid-Cap Biotech Buyout Targets In 2026
The biotech sector began December with notable weakness, as both IBB and XBI ETFs declined over two percent during trading on Monday. The sector has bounced back since. However, small biotech stocks have been on a huge run since mid-September, due primarily to a notable uptick in M&A activity across the industry. Numerous small and midcap biotech/biopharma stocks have been purchased for significant buyout premiums in recent months.
Dec 03, 2025 | seekingalpha.com
Halper Sadeh LLC Encourages RNA, TCBX, ATXS, FSUN Shareholders to Contact the Firm to Discuss Their Rights
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
Dec 01, 2025 | www.prnewswire.com
Avidity Biosciences Announces U.S. Managed Access Program (MAP) for Investigational Therapy del-zota in DMD44
SAN DIEGO , Nov. 19, 2025 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced its Managed Access Program (MAP) for investigational therapy delpacibart zotadirsen (del-zota) for eligible people with Duchenne muscular dystrophy mutations amenable to exon 44 skipping (DMD44) in the United States. "We recognize the considerable needs facing the DMD44 community given there are no approved exon skipping therapies for this disease as well as the potential of del-zota based on the unprecedented data shown in our clinical studies," said Sarah Boyce, President and Chief Executive Officer of Avidity.
Nov 19, 2025 | www.prnewswire.com
Avidity Biosciences, Inc. (RNA) Reports Q3 Loss, Beats Revenue Estimates
Avidity Biosciences, Inc. (RNA) came out with a quarterly loss of $1.27 per share versus the Zacks Consensus Estimate of a loss of $1.05. This compares to a loss of $0.65 per share a year ago.
Nov 10, 2025 | www.zacks.com
Avidity Biosciences Reports Third Quarter 2025 Financial Results and Recent Highlights
Announced Novartis agreement to acquire Avidity for total equity value of approximately $12 billion; Avidity expects to separate its early-stage precision cardiology programs into a new public company ("SpinCo") Clear path forward aligned with FDA following pre-BLA meeting for del-zota, with BLA submission planned for 2026 Del-zota one-year data demonstrated sustained muscle protection leading to meaningful improvement and reversal of disease progression across multiple key functional measures Strong balance sheet with ~$1.9 billion in cash, cash equivalents, and marketable securities SAN DIEGO , Nov. 10, 2025 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™) to profoundly improve people's lives, today reported financial results for the third quarter ended September 30, 2025, and highlighted recent progress. "In October, we announced that Avidity entered into a definitive merger agreement with Novartis, which we believe maximizes value for our investors, accelerates the global reach of our innovative neuroscience pipeline, and advances even more possibilities for our innovative science," said Sarah Boyce, president and chief executive officer of Avidity.
Nov 10, 2025 | www.prnewswire.com
Here's Why Avidity Biosciences Stock Soared This Week (There's More to the Deal Than You Might Think)
Avidity is at the forefront of an exciting new class of treatments. Avidity shareholders will receive consideration for an exciting spinoff before Novartis acquires Avidity.
Oct 31, 2025 | www.fool.com
Analysts Estimate Avidity Biosciences, Inc. (RNA) to Report a Decline in Earnings: What to Look Out for
Avidity Biosciences (RNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Oct 30, 2025 | www.zacks.com

VidIt's Email Address Formats

VidIt uses at least 1 format(s):

VidIt Email Formats	Example	Percentage
First@vidit.com	John@vidit.com	38%
First.Last@vidit.com	John.Doe@vidit.com	12%
First@vidit.com	John@vidit.com	38%
First.Last@vidit.com	John.Doe@vidit.com	12%

Frequently Asked Questions

Where is VidIt's headquarters located?

VidIt's main headquarters is located at 1536 North Woodland Park Drive, Suite #130. The company has employees across 2 continents, including AsiaNorth America.

What is VidIt's stock symbol?

VidIt is a publicly traded company; the company's stock symbol is RNA.

What is VidIt's official website and social media links?

VidIt's official website is vidit.com and has social profiles on LinkedIn.

What is VidIt's NAICS code?

VidIt's NAICS code is 5415 - Computer Systems Design and Related Services.

How many employees does VidIt have currently?

As of December 2025, VidIt has approximately 9 employees across 2 continents, including AsiaNorth America. Key team members include Vp Of Sales: G. K.Director Of Blockchain: R. J.. Explore VidIt's employee directory with LeadIQ.

What industry does VidIt belong to?

VidIt operates in the Technology, Information and Internet industry.

What technology does VidIt use?

VidIt's tech stack includes WordPressCloudflareNuxt.jsVue.jsVideo.jsHighLevelPHPreCAPTCHA.

What is VidIt's email format?

VidIt's email format typically follows the pattern of First@vidit.com. Find more VidIt email formats with LeadIQ.

When was VidIt founded?

VidIt was founded in 2007.

VidIt

Q: What is VidIt's official website and social media links?

VidIt's official website is vidit.com. VidIt has social profiles on LinkedIn.

Q: How many employees does VidIt have currently?

VidIt has approximately 9 employees.

Q: What technology does VidIt use?

VidIt's tech stack includes Microsoft IIS, Google Maps, IONOS, Cloudflare CDN, Bootstrap.

Technology, Information and InternetUtah, United States2-10 Employees

VidIt is the leading platform enabling everyone to be an Augmented Reality creator and to share their passion and personal creative expression through the Augmented Reality experiences